TABLE 4:
Survival statistics for patients with better- and worse-prognosis melanoma brain metastasis
Median Survival (mos) |
|||
---|---|---|---|
Parameter |
Overall |
DS-GPA Score 0–2 |
DS-GPA Score 3–4 |
DS-GPA survival statistics* | 6.7 | 2.73–5.42 | 6.83–15.64 |
Yale SRS w/o ipilimumab | 4.9 | 3.03 | 14.67 |
Yale SRS w/ ipilimumab | 21.3 | 15.67 | 25.2 |
As reported by Sperduto et al., 2010.